secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evoke Pharma Inc (—)
CIK:        0001403708
Form:       8-K
Filed at:   2025-12-17T23:59:59+00:00
Accession:  0001193125-25-321801
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QOL Medical completes $11/share acquisition of Evoke Pharma; delisting and leadership change
--------------------------------------------------------------------------------

- Tender offer closed Dec 15 with 67.63% of shares validly tendered; merger completed Dec 17, 2025.
- Shareholders receive $11.00 per share in cash; options and warrants with exercise price below $11 also cashed out.
- Evoke shares to be delisted from Nasdaq; company intends to file Form 15 to terminate SEC registration.
- All directors resigned; CEO, CFO, CMO employment terminated as of Dec 18, 2025; successors from QOL Medical appointed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1403708/000119312525321801/0001193125-25-321801-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1403708/000119312525321801/d81175d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-321801

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer